PAA 3.03% 17.0¢ pharmaust limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-1346

  1. 2,653 Posts.
    lightbulb Created with Sketch. 1454

    PAA have been totally incapable of getting even a small SP rise on any past achievement. To think they could get us from 7c to 25c on a good MND phase 1 outcome is not realistic in my view. They had best commence the march now.

    Does it concern anyone else that we may have to go a phase 3 for dogs alone. Cash is least concern here. Major concern is that no one is interested. All these years of talks seem to be not producing much fruit Roger. Kim let the cat out of the bag. Potential partners dont see the opportunity. We are still very much trying to sell the vets the dream...not a good position. They do not appear to be falling over themselves to get MPL.


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.005(3.03%)
Mkt cap ! $82.65M
Open High Low Value Volume
17.0¢ 18.0¢ 16.8¢ $151.1K 877.6K

Buyers (Bids)

No. Vol. Price($)
4 54714 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 371375 7
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.